Entera Bio Ltd
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -56.0% | – | -2,342.1% | -5,128.6% | -1,789.0% | -3,342.9% | – | – | – | – | – | – | |
| – | 0.3% | – | 19.3% | 26.2% | 13.4% | 19.0% | – | – | – | – | – | – | |
| – | 7.1% | – | 1,049.1% | 2,209.5% | 690.2% | 1,438.1% | – | – | – | – | – | – | |
| – | -21.0% | – | 361.4% | -181.0% | 359.8% | 1,321.4% | – | – | – | – | – | – | |
| – | 0.1% | – | 0.0% | 0.0% | 3.7% | 19.0% | – | – | – | – | – | – | |
| – | -0.1% | – | – | – | -3.7% | -19.0% | – | – | – | – | – | – | |
| – | 129.8% | – | 2,133.3% | 31.0% | 3,923.2% | 31,754.8% | – | – | – | – | – | – | |
| – | 76.6% | – | -208.8% | -5,097.6% | 2,130.5% | 28,364.3% | – | – | – | – | – | – | |
| – | -56.1% | – | -2,342.1% | -5,128.6% | -1,792.7% | -3,361.9% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.